Welcome : Guest

Nano String Technologies, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Nano String Technologies, Inc., which is principally involved in Life Sciences and Diagnostics Business. Illustrated with 130 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64941
Price: $3500
Company Type: Public
Pages: 134
Date: February 2017
Market Data Tables: 130

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Nanostring Technologies, Inc.’s Sales by Product Category Worldwide (2014-2015) in Percentage for Products (Instruments, Consumables, In Vitro Diagnostic Kits), Service Revenues, and Collaboration Revenues......3
Table 2: Nanostring Technologies, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Americas, Europe & Middle East, and Asia-Pacific......4
Table 3: Nanostring Technologies, Inc.'s Sales by Product Segment Worldwide (2014) in Percentage for Product Revenue (Instruments, Consumables and In Vitro Diagnostic Kits), Service Revenue and Collaboration Revenue......5
Diagnostic Testing......7
Table 4: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs, Physician Office Labs and Others......7
Table 5: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs, Physician Office Labs and Others......8
Table 6: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......9
Table 7: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......10
Table 8: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......11
Table 9: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......12
Table 10: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......13
Table 11: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......14
Molecular Diagnostics......15
Table 12: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......15
Table 13: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......16
Table 14: Global Molecular Diagnostics (MDx) Market by Region (2015) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......17
Table 15: Molecular Diagnostic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......18
Table 16: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......19
Table 17: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......20
Table 18: Molecular Diagnostics (MDx) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......21
Table 19: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......22
Table 20: Molecular Diagnostics (MoDx) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......23
Table 21: Molecular Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......24
Table 22: Molecular Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......25
Table 23: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......26
Table 24: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......27
Table 25: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Others......28
Table 26: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......29
Table 27: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......30
Table 28: Molecular Diagnostics Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......31
Table 29: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......32
Table 30: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2015) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......33
Table 31: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2015) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......34
In Vitro Diagnostics (IVD)......35
Table 32: Global IVD Market (2014) in US$ Million......35
Table 33: In-Vitro Diagnostics (IVD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Chemistry, Hematology and Coagulation, Histology and Cytology, Immunoassays, Molecular Diagnostics, Point of Care and Others......36
Table 34: Global In Vitro Diagnostics (IVD) Market by Area (2015) - Percentage Share Breakdown by Value Sales for Clinical Chemistry, Flow Cytometry, Hematology & Blood, Histology & Cytology, Immunoassays, Microbiology & Virology, Molecular Diagnostics and Point-of-Care Testing......37
Table 35: In Vitro Diagnostics (IVD) Market by Disease Type Worldwide (2015) - Percentage Breakdown by Value for Cancers, Cardio-Vascular Diseases, Infective Diseases, and Others......38
Table 36: In Vitro Diagnostics (IVD) Market by Product Category Worldwide (2015) - Percentage Breakdown by Value for Instrumentation, and Reagents......39
Table 37: In Vitro Diagnostics (IVD) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, Flow Cytometry, HBGM, Immunoassay, MDx, and Others......40
Table 38: In Vitro Diagnostics (IVD) Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Cancer, Cardiovascular (CV), Infectious Disease, and Others......41
Table 39: In-Vitro Diagnostics (IVD) Manufacturer Market by Technology Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, HBGM (Home Blood Glucose Monitoring), Immunoassay, MDX (Molecular Diagnostics) and Others......42
Table 40: In-Vitro Diagnostics (IVD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, United States and Others......43
Table 41: In-Vitro Diagnostics Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Chemistry Product, Hematology/Coagulation, Immunoassay Systems and others......44
Table 42: In-Vitro Diagnostic Products Market by Segment in China (2015) - Percentage Share Breakdown by Value for Blood Testing, Cellular Analysis, Clinical Chemistry, Diabetes Testing, Immunoassay, Microbiology, Molecular Diagnostics, and Pathology......45
Table 43: In Vitro Diagnostics (IVD) Market by Region in Europe (2015) - Percentage Share Breakdown by Value Sales for Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Spain, Switzerland, UK, and Rest of Europe......46
Table 44: In Vitro Diagnostics (IVD) Laboratory Market by Segment in France (2015) - Percentage Share Breakdown by Value Sales for Instruments, and Reagents......47
Table 45: In Vitro Diagnostics (IVD) Market by Category in France (2015) - Percentage Share Breakdown by Value Sales for Laboratory in Vitro Diagnostics, and Self-Monitoring of Blood Glucose......48
Genomic Technology......49
Table 46: Genomic Technology (Academic, Government, Applied Markets, Biopharma, Diagnostic Labs) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......49
Table 47: Genomic Technology for Applied Markets Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......50
Table 48: Genomic Technology for Biopharma Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......51
Table 49: Genomic Technology for Diagnostic Labs Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......52
Table 50: Genomic Technology for Academic/Government Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......53
Genomic Tools......54
Table 51: Genomics Tools Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for DNA Microarrays, Fluorescent in Situ Hybridization (FISH), Polymerase Chain Reaction (PCR), Sequencing, and Miscellaneous Reagents......54
Genomics 2.0......55
Table 52: Genomics 2.0 Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......55
Table 53: Genomics 2.0 Market for Oncology by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......56
Table 54: Genomics 2.0 for Reproductive Health Carrier Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......57
Table 55: Genomics 2.0 for Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......58
Table 56: Genomics 2.0 for Consumer Genomics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......59
Table 57: Genomics 2.0 for Forensics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......60
Table 58: Genomics 2.0 for Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......61
Table 59: Genomics 2.0 for In Vitro Fertilization (IVF) Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......62
Table 60: Genomics 2.0 for Livestock and Agriculture Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......63
Table 61: Genomics 2.0 for Microbiology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......64
Table 62: Genomics 2.0 for Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......65
Table 63: Genomics 2.0 for Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......66
Table 64: Genomics 2.0 for Reproductive Health Non-Invasive Prenatal Testing (NIPT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......67
Table 65: Genomics 2.0 for Transplant, Human leukocyte antigen (HLA) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......68
Table 66: Genomics 2.0 Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......69
Cancer Drugs......70
Table 67: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......70
Table 68: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......71
Cancer Market......72
Table 69: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......72
Table 70: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......73
Table 71: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......74
Table 72: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......75
Table 73: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......76
Table 74: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......77
Table 75: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......78
Table 76: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......79
Cancer Patients......80
Table 77: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......80
Table 78: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......81
Table 79: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......82
Table 80: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......83
Table 81: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......84
Table 82: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......85
Table 83: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......86
Table 84: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......87
Table 85: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......88
Table 86: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......89
Table 87: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......90
Table 88: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......91
Table 89: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......92
Table 90: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......93
Table 91: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......94
Table 92: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......95
Table 93: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......96
Table 94: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......97
Table 95: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......98
Table 96: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......99
Table 97: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......100
Cervical Cancer......101
Table 98: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......101
Table 99: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......102
Hematological Cancer......103
Table 100: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......103
Skin Cancer......104
Table 101: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......104
Cancer-Associated Mucositis......105
Table 102: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......105
Chronic Myelogenous Leukemia (CML)......106
Table 103: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......106
Multiple Myeloma......107
Table 104: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......107
Table 105: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......108
Infectious Disease Drugs......109
Table 106: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......109
Table 107: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......110
Diagnostic Testing......111
Table 108: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......111
Molecular Diagnostics......112
Table 109: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......112
Table 110: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......113
Table 111: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......114
In Vitro Diagnostics (IVD)......115
Table 112: Market Shares of Leading In Vitro Diagnostics (IVD) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories (ABT), Alere, Inc. (ALR), Bayer AG (BAYN), Becton, Dickinson and Company (BDX), BioMerieux SA (BIM), Bio-Rad Laboratories, Inc. (BIO), Danaher Corporation (DHR), Hologic, Inc. (HOLX), LifeScan, Inc., Ortho-Clinical Diagnostics, Inc., Rogers Corporation (ROG), Siemens AG (SIE), Sysmex Corporation, Thermo Fisher Scientific (TMO), Werfen Group, and Others......115
Table 113: Market Shares of Leading In Vitro Diagnostics (IVD) Instrumentation (Mid to High throughput Analyzer) Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Hitachi, Ltd., Invetech, KMC Systems Inc., Stratec Biomedical AG, Tecan Group Ltd., and Others......116
Table 114: Market Shares of Leading In-Vitro Diagnostics (IVD) Laboratory Service Providers Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bio-Reference Laboratories, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Quest Diagnostics, Inc. and Others......117
Table 115: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Alere, Inc., Danaher Corporation, LifeScan, Inc., Roche Holdings, Inc., System Industrie Electronic GmbH, Thermo Fisher Scientific, Inc., and Others......118
Table 116: Market Shares of Leading In-Vitro Diagnostics (IVD) Product Developers Worldwide (2015) - Percentage Breakdown by Value for Abbott Laboratories, Beckman Coulter, Inc., Johnson & Johnson, Roche Molecular Systems, Inc., Siemens AG and Others......119
Table 117: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers in China (2015) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Mindray Medical International Limited, Roche Holdings, Inc., and Others......120
Table 118: Market Shares of Leading In Vitro Diagnostics (IVDs) Companies in the US (2014) - Percentage Share Breakdown by Value for Abbott Laboratories, BioMérieux, Danaher Corporation, The, F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG, and Others......121
Genomics 2.0......122
Table 119: Market Shares of Leading Genomics 2.0 Service Providers in the US (2015) - Percentage Breakdown by Value for Illumina, Inc., Thermo Fisher Scientific Corporation, and Others......122
Cancer Drugs......123
Table 120: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......123
Table 121: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......124
Table 122: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......125
Table 123: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......126
Table 124: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......127
Breast Cancer Drugs......128
Table 125: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......128
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......129
Table 126: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......129
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......130
Table 127: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......130
Table 128: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......131
Infectious Disease Drugs......132
Table 129: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......132
Table 130: Nanostring Technologies, Inc.'s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Americas, Europe & Middle East and Asia-Pacific......133